The World's Greatest Investing Community
Results 21 - 30 of 1709 : Previous 1 2 3 4 5 6 7 8 9 Next
A Bad Year for the 6,300% Miracle
Human Genome Sciences falls from grace.
These two simple metrics can save you a lot of pain.
This Just In: Upgrades and Downgrades
Why doesn't MKM like Lilly?
2-Star Stocks Poised to Plunge: Progenics?
Market-lagging returns could be written in this 2-Star.
Prestige Brands Shares Surged: What You Need to Know
Is this meaningful? Or just another movement?
Checking the Quality of Gilead's Growth
These two simple metrics can save you a lot of pain.
1 Reason Perrigo May Be Headed for a Slowdown
Don't just ask, "How much inventory?" Ask, "What kind?"
Flamel Shares Flamed Out: What You Need to Know
Is this meaningful? Or just another movement?
Merck Chief Defends $8B R&D Budget As Vital Long-Term Investment
Is this the right direction for pharma to be going in?
Dividend? Buyback? Here's How to Get Both.
But will there be enough to replenish the pipeline?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK